Daraasad lagu daabacay Jaantuska Caafimaadka ee Britishka ayaa muujisay in daawaynta hypotyroidism subclinical muddada uurka ay yareyn karto halista dhiciska. Isla markaa, cilmi-baarayaasha ayaa ogaaday in haweenka lagu daaweeyo hypothyroidism ay la kulmaan halis dheeraad ah ee dhibaatooyinka uurka ee ay ku jiraan dhalmada waqtiga hore, preeclampsia, iyo sonkorowga uurka.
Ku saabsan Daraasadda
Daraasaddan ayaa qiimaysay in ka badan 5,000 oo haween ah kuwaas oo ahaa qaliinka hypothyroid-ka, oo leh qiyaasta hoormoonka kicinta (thyroid stimulating hormone (TSH) inta u dhaxeysa 2.5 iyo 10 mIU / L. Cilmi baadhayaashu waxay ogaadeen in haweenka lagu daaweeyo daawooyinka hoormoonka hormoonnada hormoonka tayroodhka ah ay hoos u dhaceen 38 boqolkiiba halista dhiciska, marka la barbardhigo kooxda aan la daaweyn. Muhiimad ahaan, natiijooyinka waxay kaliya u adeegsadeen haweenka qaba heerkii TSH ee 4.1 mIU / L oo ka sareeya daaweynta ka hor.
Khatarta dhicis la'aanta ee aan dhicin laguma arag dumarka Qaaxada Qaaxada laga helay 2.5 ilaa 4.0 mIU / L. Xaqiiqdii, haweenkani waxay halis weyn ugu jiraan inay ku dhacaan dhiig-karka uur-ku-jirka - xaalad keeni karta cudurka pre-eclampsia.
Cudurka Preeclampsia waa xaalad horumarin kara uurka oo keena cadaadis dhiig oo sarreeya. Preeclampsia waxay u horseedi kartaa eclampsia oo buuxa, taas oo keeni karta beerka ama kelyaha oo shaqeyn waaya, wadnaha oo aan shaqeynin, qalalaaso, qalalaaso, waxayna u dhiman karaan labada hooyo iyo ilmaha.
Isbedelada Tilmaamaha
Daraasadu waxay sharraxaysaa isbedelka talooyinka haweenka muddada uurka. Waagii hore, daaweynta waxaa lagula taliyay haweenka uurka leh ee qaba hypothyroidism oo heerarka hoormoonada (TSH) heerarka hormoonada (TSH) uu hoos u dhacay intii u dhexeysay 2.5 iyo 4.0 mIU / L.
Ururka Aids-ka Maraykanka (ATA) ayaa sidoo kale soo saaray jaan-gooyooyin cusub sannadka 2017 kuwaas oo ku dhajiya talooyinka qoraallada caafimaadka ee British Medical Journal .
Sida laga soo xigtay ATA, sababtoo ah caddaymaha ah in natiijooyinka uurka ay si xun u saameyn karto, khabiirada tilmaamuhu waxay kugula talinayaan daaweynta haweenka qaba hypothyroidism, taas oo lagu qeexay heerka sare ee TSH ee 4.1 mIU / L.
Daaweynta waxaa loo tixgelin karaa dumarka qaba hypotyroidism-qaaxo u dhaxeysa 2.5 illaa 4.0 mIU / L-haddii ay qabaan difaaca jirka ee kor u kaca (TPO) ee difaaca jirka oo caddaynaya xanuunka kansarka Hashimoto ee thyroiditis.
Sida laga soo xigtay qoraaga hoggaanka sare, Spyridoula Maraka, MD:
Kordhinta bixinta daaweynta hoormoonka tayroodhka si loo yareeyo khatarta uurarka uurka waxay macquul u tahay haweenka qaba KH-yada Qaab-hoosaadka ee 4.1-10.0 mIU / L. Si kastaba ha noqotee, marka la eego tirada yar ee saameynta haweenka qaba heerka hoose ee TSH ee 2.5-4.0 mIU / L, iyo marka la eego khatarta sii kordhaysa ee dhacdooyinka kale ee waxyeellada ah, daaweynta waxaa laga yaabaa in loo baahdo in laga takhaluso kooxdan.
Sida lagu xusay, si kastaba ha ahaatee, tilmaamaha ATA waxay ku talinayaan in dhakhtarradu tixgeliyaan xaaladda haweenka ee TPO ee ah inay qaataan go'aanka lagu daaweynayo hypotyroidal subclinical. Daaweyntu weli waa la siin karaa dumarka TPO-positive oo leh qiyaasta TSH ee u dhaxeysa 2.5 ilaa 4.0 mIU / L.
Waa maxay qanjirka 'hypothyroidism'?
Hooska 'hypothyroidism' wuxuu saameyn ku yeeshaa qiyaastii boqolkiiba 15 dumarka American ah inta uurka leh.
Haysashada heerarka ku filan ee hoormoonka tayroodh ayaa lagama maarmaan u ah horumarka naasnuujinta ee ilmaha caloosha, gaar ahaan inta lagu jiro seddexda bilood ee ugu horreysa, marka hooyadu siiso hormoonka tayroodhka uurjiifka. Saddexda bilood ee ugu horreysa, tayroodhka uur-jiifku wuxuu soo saaraa oo bilaabaa inuu soo saaro hoormoonka tayroodhka ee gaarka ah, si uu u buuxiyo hormoonka tayroodhka mato.
Hooyo hypothyroidism inta lagu guda jiro uurka waxay la xiriirtaa natiijooyin kala duwan oo uur leh, oo ay ku jiraan dhicin, dhicis, miisaanka dhalmada yar, dhalmada, cudurka pre-eclampsia, sonkorowga uurka, iyo hoos u dhaca heerka IQ ee carruurta.
Talaabooyinkaaga Xiga?
Haddii aad uur leedahay oo aad qabtid hypothyroidism-laakiin waxaad tahay TPO-diidmada - cilmi-baarayaashu waxay kugula talinayaan wadahadal dhakhtarkaaga. Sida laga soo xigtay natiijooyinka daraasadda:
Si loo fududeeyo habka go'aan qaadashada haweenka uurka leh ee qaba hypotyroidism, kiliiniyeyaasha waxaa lagu dhiirigelinayaa inay isticmaalaan habka go'aan qaadashada ee wadaag ah. Nidaamkan, kiliiniyeyaashu waxay kala hadli karaan bukaannada aan hubinaynin talooyinka daaweynteena iyo in ay sahamiyaan waxa muhiimka u ah iyaga markay go'aan ka gaari karaan caafimaadka iyaga oo ujeedadoodu tahay inay gaadhaan go'aamo ku saabsan daaweynta ugu haboon xaaladda.
Ereyga
Waxaa muhiim ah in la tilmaamo in daraasaddu ay tahay mid indho-indheyn ah, mana ahan tijaabo baaritaan oo keli ah. Si loo dhamaystiro, cilmi baaris dheeraad ah ayaa loo baahan yahay si loo ogaado haddii la siinayo beddelidda hoormoonka tayroodhka ee haweenka uurka leh waxay hagaajineysaa fursadda helitaanka uur caafimaad leh, ama si loo qeexo meel gaar ah oo la gooyo oo loogu talagalay haweenka qaba cudurka hypothyroidism inta lagu guda jiro uurka.
Arrin kale oo u qalma waxbarasho dheeraad ah waa waqtiga daaweynta. Dhibaatada ugu badani waxay dhacdaa inta lagu jiro muddada ugu horreysa ee saddexda bilood ee ugu horeeya, isla xilligaas marka uurjiifku ku tiirsanaado hooyada sida ilaha hoormoonka tayroodhka. Cilmi baarayaashu waxay ku qiyaaseen in suurtogal ah in daaweynta hypothyroidism-ka loo baahan yahay oo kaliya loo baahan yahay inta lagu jiro muddada ugu horreysa ee uurka. Cilmi-baaris dheeraad ah oo ku saabsan arrimahan ayaa kaa caawin doona in aad caddeeysid arimahan.
> Ilo:
> Elizabeth AE, et. al. "2017 Tilmaamaha Ururka Astaamaha Ameerikaanka ee loogu talagalay Cilimaadka iyo Maareynta Cudurka Qaaxada ee Uurka iyo Dhalmada Kadib." Thyroid, Volume 27, Number 3, 2017. Online: http://online.liebertpub.com/doi/pdfplus/10.1089/thy.2016.0457
> Spyridoula M et. al. "Daaweynta hoormoonka hoormoonka ee haweenka uurka leh ee qaba hypopyroidism subclinical: Daraasadda qaran ee Maraykanka" Journal of Medical Medical. J 2017; 356: i6865 doi: 10.1136 / bmj.i6865 2017. Online: http://www.bmj.com/content/bmj/356/bmj.i6865.full.pdf